Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro
REGENT
The REGENT Study: Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro
1 other identifier
observational
1,308
1 country
1
Brief Summary
The REGENT study (Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro) is a epidemiological study that try to identify and clinically describe questions about genetic renal diseases in a southeast Brazilian population undergoing renal replacement therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2017
CompletedStudy Start
First participant enrolled
March 20, 2017
CompletedFirst Posted
Study publicly available on registry
April 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2020
CompletedSeptember 22, 2020
August 1, 2019
2.8 years
March 20, 2017
September 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Frequency and numbers of patients with renal familial diseases that are on renal replacement therapy in southeast Brazil.
We will proceed a clinical interview using a questionnaire focused on the family history, among each Brazilian patients from dialysis or transplant center from the region of Niteroi/Rio de Janeiro. Patients with a positive history of familial disease will be included as a "case of familial renal disease". The results of the interviews will be analysed to create a report about incidence and prevalence of genetic renal disease among the southeast Brazilian people. At the same time we are creating a genetic reservoir to characterization of renal diseases in southeast of Brazil and we are also creating the basis to a cohort study based these families, through a new recently created outpatient unit to take care of familial renal diseases to follow all these involved renal families.
The familial epidemiological results will be ready up to 24 months form the start of the study.
Secondary Outcomes (1)
Frequency of uromodulin and APOL-1 mutation in southeast Brazilian patients underwent renal replacement therapy
From the time to DNA extraction, by using molecular studies, the DNA samples of each index cases will be analyised to uromodulin and APOL1, up to 48 months.
Study Arms (2)
CKD patients
'blood collection' Patients with chronic kidney disease in renal replacement therapy living in the sanitary administrative region of Niteroi/Rio de Janeiro. They will be interviewed about past history of familiar renal disease. They will have blood functional renal biochemistry analysed.
Renal Familiar Disease
'blood collection' They will have blood tested to renal genetic diseases
Interventions
They will have blood tested to renal genetic diseases
Eligibility Criteria
The population to be studied will be formed by southeast Brazilians that are on renal replacement therapy as dialysis or kidney transplantation. Such patients with renal diseases will answer a questionnaire about familial involvement. Some of them will be characterized as a familial index case of not yet determined genetic kidney disease.
You may qualify if:
- Brazilian patients underwent any type of renal replacement therapy, dialysis or kidney transplantation living in the area of Niteroi/Rio de Janeiro.
- Relatives among the familial people of the index cases.
You may not qualify if:
- Diabetic Nephropathy
- Non-familial cases of known Glomerulonephritis
- Refuse in participating of interview and blood collection to genetic tests
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal Fluminense
Niterói, Rio de Janeiro, 24033900, Brazil
Biospecimen
A blood collection of patients with familial history of renal disease will be done to extract DNA and to perform analysis of mutations and sequencing. After that, the samples will not be retained.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jorge R Almeida, MD, PhD
Universidade Federal Fluminense
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 20, 2017
First Posted
April 14, 2017
Study Start
March 20, 2017
Primary Completion
December 20, 2019
Study Completion
September 19, 2020
Last Updated
September 22, 2020
Record last verified: 2019-08